GSK EBITDA 2010-2024 | GSK

GSK EBITDA for the quarter ending September 30, 2024 was $1.528B, a 52.46% decline year-over-year.

  • GSK 2023 EBITDA was 11.244B, a 5.95% increase from 2022.
  • GSK 2022 EBITDA was 10.613B, a 24.46% increase from 2021.
  • GSK 2021 EBITDA was 8.527B, a 34.47% decline from 2020.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.

GSK EBITDA 2010-2024 | GSK

  • GSK 2023 EBITDA was 11.244B, a 5.95% increase from 2022.
  • GSK 2022 EBITDA was 10.613B, a 24.46% increase from 2021.
  • GSK 2021 EBITDA was 8.527B, a 34.47% decline from 2020.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.